ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

リザトリプタン安息香酸塩

Rizatriptan Benzoate

HCID 77997
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
145202-66-0
標準SMILES
CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1
InChIKey
JPRXYLQNJJVCMZ-UHFFFAOYSA-N
分子式
C22H25N5O2
平均分子量
391.5 g/mol
単同位体質量
391.20082506

概要

Rizatriptan benzoate is a member of tryptamines.

名称と識別子

優先名称
Rizatriptan Benzoate
IUPAC
benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
現地名
リザトリプタン安息香酸塩
英語名
Rizatriptan benzoate
分子式
C22H25N5O2
分子量
391.48

名称と別名

Rizatriptan benzoate145202-66-0Maxalt-MLTRIZAFILMWR978S7QHHNSC-758919L 705126L 705,126L-705,126DTXSID201629371H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoateSYMBRAVO COMPONENT RIZATRIPTAN BENZOATE
名称をさらに表示
リザトリプタン安息香酸塩N,N-ジメチル-2-[5-(1,2,4-トリアゾール-1-イルメチル)-1H-インドール-3-イル]エチルアミン安息香酸塩安息香酸リザトリプタンリザトリプタン安息香酸塩 (JAN)マクサルトRPDN,N-ジメチル-2-[5-[(1H-1,2,4-トリアゾール-1-イル)メチル]-1H-インドール-3-イル]エタンアミン・安息香酸N,N-ジメチル-2-[5-(1H-1,2,4-トリアゾール-1-イルメチル)-1H-インドール-3-イル]エタンアミン・安息香酸マクサルトN,N-ジメチル-5-(1H-1,2,4-トリアゾール-1-イルメチル)-1H-インドール-3-エタンアミン・安息香酸リザトリプタン・安息香酸MK-462安息香酸・リザトリプタンMK-462MK-0462RizatrimptanMK-462 BenzoateRizatriptan APIRizatriptan BenzoatExatecan (Standard)Rizatriptani benzoas
3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate3-[2-(Dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoateRefChem:58236Rizatriptan Benzoate ODTDTXCID80854281H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, benzoate (1:1)604-465-6Maxalt

物性

構造計算による物性

極性表面積
87 Ų
水素結合供与体数
2
水素結合受容体数
5
回転可能結合数
6
重原子数
29
形式電荷
0
複雑度
412

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section160.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
178 · 178-180°C
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: ≥5mg/mL
外見
粉
色
白からベージュ
水溶解度
2 O: · H2O: ≥5mg/mL
Merck
14 · 14,8241
InChI
InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)
InChIKey
JPRXYLQNJJVCMZ-UHFFFAOYSA-N
SMILES
C(C1C=CC=CC=1)(=O)O.C(C1=CNC2C=CC(CN3N=CN=C3)=CC1=2)CN(C)C
CAS データベース
145202 · 145202-66-0(CAS DataBase Reference)

化学的性質

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H302 (35.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P304+P340, P305+P351+P338, P318, P319, P330, P337+P317, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 149 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (35.6%)

毒性情報

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Rizatriptan benzoate

vLess-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

安全データ

wgk
3
hs_code
2933995500
risk_code
61
hazard_code
T
Hazard Classifications
Repr. 1B
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

化学と産業

薬理情報

FDA Pharmacological Classification · 4 件

RIZATRIPTAN BENZOATE

Serotonin 1d Receptor Agonists [MoA]; Serotonin 1b Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

RIZATRIPTAN BENZOATE ODT

Serotonin 1d Receptor Agonists [MoA]; Serotonin 1b Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

MeSH Pharmacological ClassificationEndogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.

用途と製造

UsesUse (kg) in USA (2002): 57
応用分野 · 4 件

用途5-HT1B 及び5-HT1D 受容体に 作用します。血管収縮作用及び血管拡張物質 抑制作用を示します。

説明Rizatriptan was launched for the first time as Maxalt in Mexico for the acute treatment of migraine headaches with or without aura in adults. It is the third in a new generation of triptan migraine drugs to challenge the firstgeneration product Sumatriptan from Glaxo Wellcome, after Zolmitriptan (Zeneca) and Naratriptan (Glaxo Wellcome). It can be synthetically obtained by two related routes having respectively 3 and 4 steps, both starting from 1 -(4-aminobenzyl)-l,2,4-triazole. Rizatriptan is a full 5-HT1D/1B receptor agonist retaining a significant affinity at 5-HT1A sites (pIC50 = 6.4), with a low affinity for nond-HT sites. It shows craniovascufar selectivity for human isolated middle meningeal over coronary arteries ; its effect on coronary artery constriction is significantly less than that for Sumatriptan. Rizatriptan inhibits the release of neuropeptides that cause swelling of cranial blood vessels. Rizatriptan has a good oral bioavailability (64% and 47% in rats and dogs respectively). and a rapid onset of action : the headache relief in human occurs within 30 to 45 minutes of taking 20 mg. It also relieved nausea and hypersensitivity to noise (phonophobia) and light (photophobia) that are often symptoms accompanying a migraine attack. Among at least 6 metabolites identified in humans after a single oral dose (60 mg), the major urinary metabolite was the corresponding indole-3-acetic acid. Maxalt is available as a novel oral formulation of rapidly dissolving tablets or wafers that does not require liquid for ingestion.

関連反応

1 件
反応記録を作成
HRID 1180101 の反応式
HRID 1180101生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
145202-66-0
PubChem CID
77997
DTXSID
DTXSID20162937
ChEMBL
CHEMBL1201032
ChEBI
CHEBI:8875
UNII
WR978S7QHH
EC Number
604-465-6

化学的特性Off-White Solid

使用Rizatriptan Benzoate is a selective serotonin 5-HTID receptor agonist and used to treat migraine (1,2,3). It is structurally derived from tryptamine.

一般的な説明Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards